People with extreme, life-threatening allergic reactions might do as well to use a nasal spray as to jab themselves in a ...
Polyrizon Ltd. ( ($PLRZ) ) has shared an update. On November 6, 2025, Polyrizon Ltd. announced positive in-vitro results for its PL-16 Viral ...
The Health Canada authorization marks an important regulatory milestone in the NS002 development program. This clearance confirms the acceptability of the proposed trial design, supporting safety data ...